Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Monday, November 9 2009 9:18am ET - U.S. Markets open in 12 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > SEQUENOM, Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
SEQUENOM, Inc. Company Profile
Gene sequencing is no dream sequence for SEQUENOM. The company sheds light on the genetic underpinnings of life with its MassARRAY sequencing system that is used to analyze variations in DNA called single nucleotide polymorphisms (SNPs). The system is composed of electronic analysis equipment and related software. Consumables used in the analysis process include SpectroCHIP branded arrays and reagent kits. The company sells its products directly in the US, Europe, and select Asian countries, as well as through distributors in other regions. Customers include clinical research labs, biotech companies, and universities.
Headlines for SEQUENOM, Inc.
Q3 2009 Sequenom Earnings Release - After Market Close
CCBN - 2 hours, 10 minutes ago
SEQUENOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online - Thu Nov 5
Sequenom Earnings Call scheduled for Mon, Nov 9
CCBN - Wed Nov 4
SEQUENOM Announces Date of Third Quarter 2009 Financial Results and Conference Call
PR Newswire - Wed Nov 4
More Headlines...
More on SEQUENOM, Inc.
Quote SEC
Chart Msgs
News Insider
Profile Financials
Reports Analyst Ratings
Research    
Contact Information
Address: 3595 John Hopkins Ct.
San Diego, CA 92121-1331
Phone:858-202-9000
Fax:858-202-9001
Financial Highlights
Fiscal Year End:December
Revenue (2008):47.10 M
Revenue Growth (1 yr):15.00%
Employees (2008):248
Employee Growth (1 yr):29.20%
Key People
Chairman and Interim CEO: Harry F. Hixson Jr.
VP Operations: Larry Myres
Principal Financial and Accounting Officer: Justin J. File
Industry Information
Sector: Healthcare
Industry: Biotechnology
Top Competitors
Biotage AB
Illumina, Inc. (ilmn)
Life Technologies Corporation (life)
 


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?